Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
European Journal of Haematology|May 4, 2011
Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantationCecilie Blimark, Ljupco Veskovski, Jan Westin, et al.
BMC Pregnancy and Childbirth|May 9, 2025
Extra-uterine placental transfusion and intact-cord stabilisation of infants in caesarean sections: an intervention development and pilot-study (INTACT-1)Elisabeth Saether, Ola Andersson, Solveig Bjellmo, et al.
Nanoscale|May 9, 2015
Dimer-on-mirror SERS substrates with attogram sensitivity fabricated by colloidal lithographyAron Hakonen, Mikael Svedendahl, Robin Ogier, et al.
British Journal of Haematology|May 5, 2021
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based studyAmal Abu Sabaa, Charlott Mörth, Sverker Hasselblom, et al.
Oncotarget|April 21, 2016
Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cellsOlle Werlenius, Johan Aurelius, Alexander Hallner, et al.
Epigenetics & Chromatin|January 9, 2019
Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemiaSara Wernig-Zorc, Mukesh Pratap Yadav, Pradeep Kumar Kopparapu, et al.
American Journal of Hematology|March 18, 2020
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphomaTove Wästerlid, Sara Harrysson, Therese M-L Andersson, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 11, 2023
Hyper high haemoglobin content in red blood cells and erythropoietic transitions postnatally in infants of 22 to 26 weeks' gestation: a prospective cohort studySara Marie Larsson, Tommy Ulinder, Alexander Rakow, et al.
Ejhaem|June 19, 2024
The choice of serum-free light chain analysis method could potentially have clinical consequences for myeloma patientsLjupco Veskovski, Ingvar Jakobsson, Per-Ola Andersson, et al.
Scientific Reports|December 20, 2023
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulinMikael Lisak, Malin Nicklasson, Robert Palmason, et al.
Pageof 17